RHJA
PBH icon

Rice Hall James & Associates’s Prestige Consumer Healthcare PBH Stock Holding History

Rice Hall James & Associates’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$30.9M Buy
521,622
+21,022
+4% +$1.36M 1.72% 12
2025
Q4 		$30.9M Sell
500,600
-9,068
-2% -$555K 1.7% 13
2025
Q3 		$31.8M Sell
509,668
-30,225
-6% -$2.1M 1.73% 12
2025
Q2 		$43.1M Sell
539,893
-5,235
-1% -$438K 2.32% 7
2025
Q1 		$46.9M Sell
545,128
-5,684
-1% -$466K 2.75% 5
2024
Q4 		$43M Sell
550,812
-22,722
-4% -$1.76M 2.36% 7
2024
Q3 		$41.4M Sell
573,534
-18,723
-3% -$1.33M 2.24% 8
2024
Q2 		$40.8M Sell
592,257
-37,822
-6% -$2.56M 2.45% 8
2024
Q1 		$45.7M Sell
630,079
-36,534
-5% -$2.44M 2.61% 7
2023
Q4 		$40.8M Buy
666,613
+112,423
+20% +$6.68M 2.36% 6
2023
Q3 		$31.7M Sell
554,190
-9,480
-2% -$573K 2.01% 9
2023
Q2 		$33.5M Sell
563,670
-7,593
-1% -$454K 1.9% 11
2023
Q1 		$35.8M Sell
571,263
-54,896
-9% -$3.43M 2.03% 8
2022
Q4 		$39.2M Sell
626,159
-841
-0.1% -$48.2K 2.25% 6
2022
Q3 		$31.2M Sell
627,000
-122,025
-16% -$6.76M 1.81% 10
2022
Q2 		$44M Sell
749,025
-19,672
-3% -$1.08M 2.13% 9
2022
Q1 		$40.7M Sell
768,697
-10,802
-1% -$624K 1.62% 13
2021
Q4 		$47.3M Sell
779,499
-20,642
-3% -$1.23M 1.68% 16
2021
Q3 		$44.9M Sell
800,141
-11,425
-1% -$627K 1.66% 14
2021
Q2 		$42.3M Sell
811,566
-150,183
-16% -$7.21M 1.5% 19
2021
Q1 		$42.4M Buy
961,749
+88,120
+10% +$3.7M 1.38% 20
2020
Q4 		$30.5M Buy
873,629
+325,677
+59% +$11.6M 1.07% 34
2020
Q3 		$20M Buy
547,952
+20,380
+4% +$758K 0.8% 39
2020
Q2 		$19.8M Sell
527,572
-17,234
-3% -$689K 0.85% 36
2020
Q1 		$20M Sell
544,806
-18,009
-3% -$699K 1.12% 27
2019
Q4 		$22.8M Sell
562,815
-14,511
-3% -$541K 0.77% 37
2019
Q3 		$20M Sell
577,326
-11,743
-2% -$387K 0.72% 46
2019
Q2 		$18.7M Sell
589,069
-31,894
-5% -$948K 0.62% 55
2019
Q1 		$18.6M Buy
620,963
+19,734
+3% +$566K 0.6% 54
2018
Q4 		$18.6M Buy
601,229
+487,610
+429% +$17.8M 0.68% 47
2018
Q3 		$4.3M Buy
+113,619
New +$4.3M 0.15% 122

Other funds holding PBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Rice Hall James & Associates's PBH Position: Q1 2026 in Review

Rice Hall James & Associates increased its Prestige Consumer Healthcare (PBH) stake by 4.2% in Q1 2026, buying an estimated $1.36M and bringing the position to 521,622 shares worth $30.9M. The position accounts for 1.72% of the portfolio, ranked #12.

Rice Hall James & Associates first reported a position in PBH in Q3 2018 and has held it in 31 quarters since. The position peaked at $47.3M in Q4 2021. 355 funds tracked by Wall St. Rank hold PBH as of Q1 2026.

  • Rice Hall James & Associates held 521,622 shares of Prestige Consumer Healthcare worth $30.9M as of Q1 2026.
  • Rice Hall James & Associates bought 21,022 Prestige Consumer Healthcare shares in Q1 2026, an estimated $1.36M.
  • Prestige Consumer Healthcare made up 1.72% of Rice Hall James & Associates's portfolio in Q1 2026, its #12 holding.
  • Rice Hall James & Associates first reported a position in Prestige Consumer Healthcare in Q3 2018 and has held it in 31 quarters since.
  • Rice Hall James & Associates's Prestige Consumer Healthcare position peaked at $47.3M in Q4 2021.
  • 355 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2026.

Based on Rice Hall James & Associates's 13F filing for Q1 2026, filed 15 May 2026.